Data on the systemic levels of VEGF and apelin-13 related to ROP have been inconclusive; thus, our results provide evidence that plasma apelin-13 and VEGF levels measured at 4–6 weeks of age may play a role in the diagnosis of ROP. The gene discussed is VEGFA; the disease is retinopathy of prematurity.